Jinhui Xue
4PUBLICATIONS
33CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Mar 24, 2026
The Oncogenic EGFR-SHC1 Fusion Confers Insensitivity to EGFR-TKIs via Dual Activation of N-EGFR Kinase Domain and C-SHC1 Phosphorylation Sites in Lung Cancer.Jiani Zheng, Shen Zhao, Jianhua Zhan
|Apr 22, 2025
Izalontamab (SI-B001), a Novel EGFRxHER3 Bispecific Antibody in Patients with Locally Advanced or Metastatic Epithelial Tumor: Results from First-in-Human Phase I/Ib Study.Jinhui Xue, Yuxiang Ma, Yuanyuan Zhao
|Jun 04, 2024
Influence of TP53 mutation on efficacy and survival in advanced EGFR-mutant non-small cell lung cancer patients treated with third-generation EGFR tyrosine kinase inhibitors.Zhonghan Zhang, Jinhui Xue, Yunpeng Yang
|Jun 01, 2023
Phase I trial of KN046, a novel bispecific antibody targeting PD-L1 and CTLA-4 in patients with advanced solid tumors.Yuxiang Ma, Jinhui Xue, Yuanyuan Zhao
Pageof 1
Frequent Collaborators
3 joint publications
Yuanyuan Zhao
2 joint publications
Hongyun Zhao
2 joint publications
Yan Huang
2 joint publications
Yunpeng Yang
2 joint publications
Wenfeng Fang
2 joint publications
Shaodong Hong
2 joint publications
Li Zhang
1 joint publications
Ye Guo
1 joint publications
Jiaxin Cao
1 joint publications
Jing Li
